Skip to main content

Vyzulta Prices, Coupons and Patient Assistance Programs

Vyzulta (latanoprostene bunod ophthalmic) is a member of the ophthalmic glaucoma agents drug class and is commonly used for Glaucoma - Open Angle, and Glaucoma/Intraocular Hypertension.

The cost for Vyzulta ophthalmic solution 0.024% is around $278 for a supply of 2.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Vyzulta is available as a brand name drug only, a generic version is not yet available. View generic Vyzulta availability for more details.

Vyzulta prices

Ophthalmic Solution

Quantity Per unit Price
2.5 milliliters $111.35 $278.37
5 milliliters $109.44 $547.22

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Vyzulta Coupons, Copay Cards and Rebates

Vyzulta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Vyzulta Bausch + Lomb Access Program

Eligible cash-paying or commercially insured/RX not covered patients may pay no more than $70 per 2.5 mL bottle/$100 per 5 mL bottle prescription; offer valid at at Walgreens or another participating pharmacy; for additional information contact the program at 866-693-4880.

Applies to:
Vyzulta
Number of uses:
6 fills per product per 12 month period

Form more information phone: 866-693-4880 or Visit website

Vyzulta Bausch + Lomb Access Program

Eligible commercially insured patients may pay as little as $25 per prescription at Walgreens or another participating pharmacy; for additional information contact the program at 866-693-4880.

Applies to:
Vyzulta
Number of uses:
6 fills per product per 12 month period

Form more information phone: 866-693-4880 or Visit website

Patient Assistance & Copay Programs for Vyzulta

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Bausch + Lomb Patient Assistance Program

Eligibility requirements:
  1. Must have no prescription coverage for needed medication
  2. Based on FPL
  3. FDA-approved diagnosis
  4. The patient must be a US citizen or legal resident.
  5. Hardship appeals for patients residing in Puerto Rico will be reviewed on a case-by-case basis. Call for information on the most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Vyzulta (latanoprostene bunod) Ophthalmic Solution/Drops

More information please phone: 855-770-0424 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.